AstraZeneca Stock Rises 4% Over Positive Data From Tozorakimab Study

(RTTNews) - Shares of AstraZeneca PLC (AZN) are gaining about 4 percent on Friday morning trading after the company announced positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease. https://www.nasdaq.com/articles/astrazeneca-stock-rises-4-over-positive-data-tozorakimab-study